Not recruitingISRCTN10534853

A study to investigate the safety and processing by the body of the drug AUT00206 in patients with schizophrenia, and to explore the effects of AUT00206 on relevant central biomarkers

Research studyAges 18+United Kingdom

The study in practice

Understand this study

This study is for people with schizophrenia. Listed age limits: from 18 years. Other eligibility criteria apply.

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Study start dateNot clearly listed

Recruitment status: Not recruiting
Enrollment listed in the registry: Not clearly listed
Sponsor: Autifony Therapeutics (United Kingdom)
Sponsor type: Biotech company
Study type: Other
Intervention type: Other / unclear
Locations: United Kingdom
Age range: Over 18 Years
Official registry ID: ISRCTN10534853
Official title: Show the full official title
A study to investigate the safety and processing by the body of the drug AUT00206 in patients with schizophrenia, and to explore the effects of AUT00206 on relevant central biomarkers

Not recruiting

United Kingdom

FAQ

Who is behind this study?

The study sponsor is Autifony Therapeutics (United Kingdom).

Who can participate?

This study is for people with schizophrenia. Listed age limits: from 18 years. Other eligibility criteria apply.

Is this study still recruiting?

The registry lists this study as not recruiting.